MALIGNANT PLEURAL EFFUSION

โœ“ Medically ReviewedDISEASEID: MDBT0201๐Ÿšจ TRIAGE: URGENTICD-10: J91.0
๐Ÿ’ก Clinical Takeaway

Confirm the diagnosis of malignant pleural effusion via cytology or biopsy before committing to palliative pleurodesis or indwelling pleural catheter placement, as management depends heavily on the primary tumour type and patient prognosis.

๐Ÿ“–

Definition

CLINICAL DEFINITION

A malignant pleural effusion (MPE) is the accumulation of exudative fluid in the pleural space containing malignant cells, confirmed by pleural fluid cytology or pleural biopsy. It represents a late-stage manifestation of systemic or primary thoracic malignancies, indicating disseminated disease and carrying a poor prognosis.

IN PLAIN ENGLISH

Malignant pleural effusion is a build-up of fluid around the lungs caused by cancer. It happens when cancer cells spread to the lining of the lungs (the pleura), causing irritation and fluid leakage, which makes it difficult to breathe.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Malignant Pleural Effusion is NOT a primary lung cancer itself, but rather a complication of cancer spreading to the pleura. It is NOT a simple transudative effusion caused by heart failure or liver disease, nor is it a parapneumonic effusion caused by bacterial pneumonia, although these must be ruled out.

MEDICAL DISCLAIMER โ€” This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.